Cancer genomics

Cancer Genomics is the investigation of genetic mutations which responsible for cancer, by using genome sequencing and bioinformatics. Clinical genomics is to enhance cancer treatment and outcomes lies in determining which sets of genes and gene interactions affect different subsets of cancers. International Cancer Genome Consortium (ICGC) is a lead scientific organization that provides a forum for collaboration among the world's leading cancer and genomic researchers.

  • Acquired mutations
  • Germline mutations
  • Tumor suppressor genes
  • Oncogenes
  • DNA repair genes

Related Conference of Cancer genomics

July 17-18, 2020

10th Glycobiology World Congress

Vienna, Austria
August 03-04, 2020

12th Euro Biosensors & Bioelectronics Congress

Zurich, Switzerland
September 22-23, 2020

International Conference on Nucleic Acids

Dubai, UAE
September 28-29, 2020

2nd International Conference on Metabolomics, Genomics and Proteomics

Singapore City, Singapore
September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
September 29-30, 2020

World Congress on Biosensors and Bioelectronics

Osaka, Japan
October 21-22, 2020

18th International Conference on Metabolomics and Proteomics

Frankfurt, Germany
December 07-08, 2020

9th World Congress on Glycobiology & Glycochemistry

Dubai, UAE
December 10-11, 2020

2nd Pathology and Infectious Disease Conference

Dubai, UAE
April 01-02, 2021

12th Tissue Science and Regeneration Congress

Abu Dhabi, UAE
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic

Cancer genomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in